Back
America Movil SAB de CV Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
45
AMX
America Movil SAB de CV
Last Price:
$20.81
Seasonality Move:
2.01%
Sell
39
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$34.13
Seasonality Move:
6.21%
Sell
45
America Movil SAB de CV (AMX)
is a Sell
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $20.87. The Score for AMX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
AMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $34.34. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $20.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMX is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $34.34The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
AMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 29.98 | Sell |
| Chaikin Money Flow: | -1487579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.51 - 23.27) | Sell |
| Bollinger Bands (100): | (19.43 - 22.61) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 48.76 | Sell |
| Chaikin Money Flow: | -1295237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Buy |
| Bollinger Bands (100): | (28.94 - 34.1) | Buy |
AMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.29 | Sell |
| 20-day SMA: | 22.16 | Sell |
| 50-day SMA: | 22.34 | Sell |
| 200-day SMA: | 18.69 | Buy |
| 8-day EMA: | 21.36 | Sell |
| 20-day EMA: | 21.88 | Sell |
| 50-day EMA: | 21.9 | Sell |
| 200-day EMA: | 19.55 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.02 | Sell |
| 20-day SMA: | 34.61 | Sell |
| 50-day SMA: | 33.59 | Buy |
| 200-day SMA: | 33.68 | Buy |
| 8-day EMA: | 35.6 | Sell |
| 20-day EMA: | 34.92 | Sell |
| 50-day EMA: | 33.67 | Buy |
| 200-day EMA: | 34.81 | Sell |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $0.19 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
America Movil SAB de CV Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||